The largest database of trusted experimental protocols

Minute cytoplasmic and nuclear fractionation kit

Manufactured by Invent Biotechnologies
Sourced in United States, China

The Minute™ Cytoplasmic and Nuclear Fractionation kit is a lab equipment product designed to separate and extract cytoplasmic and nuclear fractions from eukaryotic cells. The kit provides a simple and efficient method for the isolation of these cellular components.

Automatically generated - may contain errors

6 protocols using minute cytoplasmic and nuclear fractionation kit

1

BPIV3 Infection in LiCl-Pretreated MDBK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDBK cells were pretreated by LiCl at a final concentration of 20 mM for 24 h, and then were infected by 1 MOI BPIV3 for 24 h. After that, cells were harvested and the nucleus and cytoplasm were separated according to the manufacturer’s protocol of Minute™ Cytoplasmic and Nuclear Fractionation kit (Invent Biotechnologies, Inc) and then subjected to western blot analysis. β-actin and Lamin B1 were used as internal references of cytoplasmic and nucleus protein, respectively.
+ Open protocol
+ Expand
2

Evaluating Nrf2 and SIRT1 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nuclear extracts were prepared using the Minute Cytoplasmic and Nuclear Fractionation Kit (Invent Biotechnologies Inc., Plymouth, MN). The nuclear fractionations were then subjected to Western blotting analysis using anti-Nrf2 antibody. Total proteins were subjected to Western blotting analysis using anti-SIRT1, anti-eNOS,anti-p-eNOS, and anti-HO-1 antibody. Western blot analysis was performed as previously described (Jiang et al., 2019 (link)).
+ Open protocol
+ Expand
3

Subcellular Fractionation and NF-κB Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The nuclear and cytoplasmic fractions were separately extracted using the Minute™ Cytoplasmic and Nuclear Fractionation Kit (SC-003, Invent Biotechnologies, USA). β-Actin was used as the cytoplasmic control, and Lamin B1 was used as the nuclear control for western blotting analysis. Nuclear p65 DNA-binding activity was detected using NF-κB p65 transcription factor assays (ab210613, Abcam, UK).
+ Open protocol
+ Expand
4

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extraction and western blotting were performed as previously reported.56 (link) Briefly, total proteins were extracted from lysis buffer containing protease inhibitor cocktail (Kangchen, cat. no. KC-415), and nuclear or cytoplasmic proteins were extracted using the Minute Cytoplasmic and Nuclear Fractionation kit (Invent, cat. no. SC-003). Proteins (30 μg) were subjected to SDS-PAGE using polyacrylamide gels. Immunoblotting was performed using specific antibodies (ANP, Beyotime, cat. no. AF7608; BNP, Abcam, cat. no. ab236101; β-MHC, Abcam, cat. no. ab172967; NF-κB p65, Cell Signaling, cat. no. D14E12; IκBα, Cell Signaling, cat. no. 9242; G3BP2, Affinity Biosciences, cat. no. DF4387, TUBULIN, Beyotime, cat. no.AF1216; GAPDH, Beyotime, cat. no. AF1186 and Lamin B1, Proteintech, cat. no.12987-1-AP) to evaluate the expression of proteins. The image was acquired using the Odyssey infrared fluorescence imaging system (Li-Cor, Lincoln, NE). Band intensity was quantified by a densitometric analysis using ImageJ software (National Institutes of Health).
+ Open protocol
+ Expand
5

Investigating Nuclear Translocation of NF-κB in BP-Exposed Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophage-like dTHP-1 cells were treated with BP nanomaterials (100 μg ml−1) and BP–corona complexes for 6 h. Then the cells were washed with PBS three times and collected. The cytoplasm and nuclear extracts were prepared using the Minute™ Cytoplasmic and Nuclear Fractionation Kit (Invent Biotechnologies, Inc), and the protein concentration was determined by the Super-Bradford Protein Assay Kit (CWBiotech, Inc, Beijing, China). The expression levels of lκB in cytoplasm extracts and p65 in nuclear extracts were determined by WB according to previous literature54 (link). Briefly, the extracts were first separated by 12% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Bio-Rad, CA, USA). The membrane was blocked with 5% BSA in PBS at 25 °C for 2 h and then incubated with antibodies at 4 °C overnight. The expression of β-actin was used as the internal standard. The uncropped WB images were included in Supplementary Figure 12. The sources of primary antibody against the following protein were: β-actin (A1978, 1:10,000 for WB) from sigma; p65 in nuclear (ab16502, 1:1000 for WB), and lκB (15095, 1:1000 for WB) from Abcam. The appropriate secondary antibodies (1:10,000 for WB) were purchased from Abcam.
+ Open protocol
+ Expand
6

Subcellular Fractionation and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subcellular fractions of nuclei or cytoplasm were isolated by Minute™ Cytoplasmic and Nuclear Fractionation kit (Invent Biotechnologies, Inc.; cat. no. #SC-003) according to the manufacturers' protocol. The extracted proteins were examined via western blot using β-actin (Cell Signaling Technology, Inc. cat. no. #4970S) serving as marker for total and cytoplasmic protein, Lamin A antibody (CSignaling Technology, Inc.; cat. no. #86846S) serving as marker for nuclear protein. Western blot was performed as described in a previous study (21 (link)). Primary antibody against p53 (cat. no. #60283-2-Ig, 1:1,000), Kras (cat. no. #12063-1-AP, 1:1,000), pan-Ras (cat. no. #60309-1-Ig, 1:1,000), AKT (cat. no. #60203-2-Ig, 1:1,000), phosphorylated (p-)AKT (Ser473; cat. no. #80455-1-RR, 1:1,000), p-AKT (Thr308; cat. no. #29163-1-AP, 1:1,000), c-MYC (cat. no. #67447-1-Ig; 1:1,000), LDHA (cat. no. #21799-1-AP, 1:1,000) and GAPDH (cat. no. #60004-1-Ig, 1:2,000) were obtained from ProteinTech Group, Inc.; p-c-MYC (Ser293; cat. no. #PA5-105447, 1:2,000) was obtained from Invitrogen (Thermo Fisher Scientific, Inc.) and p-MYC (T58 + S62; cat. no. #13342, 1:1,000) was obtained from Signalway Antibody LLC. Antibodies against E-cadherin, N-cadherin, vimentin, Snail and Slug were obtained from EMT Antibody Sampler kit (cat. no. #9782; Cell Signaling Technology, Inc.; 1:1,000).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!